 Bionano Genomics Inc NASDAQ: BNGO posted preliminary Q4 sales of 5.8 million - 6.2 million, 25 - 33 sequentially, up 45 - 55 YY, and above the consensus of 5.44 million. FY21 revenue is expected to be 17.5 million - 17.9 million consensus 17.13 million, more than doubled from FY20. 